clinical trial · NCT06582264
A Phase 1b Trial to Evaluate the Safety of MB310 in Patients With Active, Mild-to-Moderate Ulcerative Colitis
Microbiotica Ltd·phase1·completed·n = 29
Ulcerative ColitisMB310PlaceboVancomycin
brief summary
A Phase 1b study to evaluate the safety and tolerability of MB310 given to patients who have active mild-to-moderate ulcerative colitis.
started
Sep 27, 2024
primary completion
Jan 8, 2026
completion
Jan 8, 2026
last updated
Feb 17, 2026
official title
A Phase 1b, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Safety, Engraftment, and Initial Signs of Clinical Activity of MB310 in Patients With Active, Mild-to-Moderate Ulcerative Colitis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol